US2011250614A1PendingUtilityA1
Methods and compositions for detecting the activation state of multiple proteins in single cells
Individually held — no corporate assignee on recordPriority: Jul 10, 2001Filed: May 2, 2011Published: Oct 13, 2011
Est. expiryJul 10, 2021(expired)· nominal 20-yr term from priority
C12Q 1/485G01N 33/582Y10T436/101666G01N 2333/91205G01N 33/5091G01N 2405/00G01N 33/54313G01N 2440/14G01N 33/5041G01N 33/5094Y10S435/973G01N 33/5302Y10T436/25G01N 33/6845G01N 33/573G01N 2333/96466G01N 33/5008G01N 21/6428G01N 2021/6441
65
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The invention provides methods and compositions for simultaneously detecting the activation state of a plurality of proteins in single cells using flow cytometry. The invention further provides methods and compositions of screening for bioactive agents capable of coordinately modulating the activity of a plurality of proteins in single cells. The methods and compositions can be used to determine the protein activation profile of a cell for predicting or diagnosing a disease state, and for monitoring treatment of a disease state.
Claims
exact text as granted — not AI-modified1 - 9 . (canceled)
10 . A method of detecting the activation state of at least a first activatable protein in single cells, said method comprising the steps of:
a) providing a population of cells comprising at least said first activatable protein; b) contacting said population of cells with a plurality of substrates; wherein said plurality of substrates comprise at least a first substrate that is capable of being modified by a corresponding isoform of said first activatable protein in said population of cells; and c) using flow cytometry to detect the modification of said first substrate in single cells of said population of cells, wherein said modification is indicative of a specific activation state of said first activatable protein.
11 . The method according to claim 10 , wherein said population of cells further comprises a second activatable protein, wherein said plurality of substrates further comprise a second substrate that is capable of being modified by a corresponding isoform of said second activable protein in said population of cells and, wherein step c) further comprises using said flow cytometry to detect the modification of said second substrate in single cells of said population of cells, wherein said modification of said second substrate is indicative of a specific activation state of said second activatable protein.
12 . A method of detecting a protein activation state profile of single cells based on the activation state of at least a first activatable protein in said cells, said method comprising the steps of:
a) providing a population of cells comprising at least said first activatable protein; b) contacting said population of cells with a plurality of substrates; wherein said plurality of substrates comprise at least a first substrate that is capable of being modified by a corresponding isoform of said first activatable protein in said population of cells; c) contacting said population of cells with a plurality of activation state-specific antibodies, wherein said activation state-specific antibodies comprise at least one first activation state-specific antibody that is capable of binding to a corresponding isoform of said first activatable protein in said population of cells; and d) using flow cytometry to simultaneously detect: i) said binding of said first activation state-specific antibody in single cells of said population of cells, wherein said binding of said first activation state-specific antibody is indicative of a specific activation, state of said first activatable protein; and ii) the modification of said first substrate said single cells, wherein said modification is indicative of said specific activation state of said first activatable protein.
13 - 32 . (canceled)Join the waitlist — get patent alerts
Track US2011250614A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.